We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 456

Release of information contained in drug submissions and medical device applications
  • Smart & Biggar/Fetherstonhaugh
  • USA, Canada
  • June 20 2018

On December 9 2017 Heath Canada released proposed amendments to the Food and Drug Regulations and the Medical Devices Regulations providing for the


Apotex not entitled to reopen trial on esomeprazole (Nexium) patent validity
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • June 18 2018

The validity of AstraZeneca's Nexium patent has finally been decided by the Supreme Court of Canada, with any doubt about the court's intent resolved


Procedural decisions relating to Herceptin under amended PMNOC Regulations
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • June 18 2018

Substantial amendments to the Patented Medicines (Notice of Compliance) (PMNOC) Regulations came into force on 21 September 2017. This update examines


Supreme Court denies leave regarding natural health product licence
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • June 13 2018

On April 12 2018 the Supreme Court dismissed The Winning Combination's leave to appeal (Docket 37697). The Federal Court of Appeal had previously set


Health Canada reports on consultations on proposed approach to cannabis regulation
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • June 6 2018

Bill C-45 - An Act respecting Cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and Other Acts - is currently before


Rx IP Update - May 2018
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • June 5 2018

This is a special update on the Protecting Canadians from Unsafe Drugs Act (Vanessa’s Law) which was approved on November 6, 2014 (as previously


Media pirates walk the plank: extraordinary remedies against copyright infringers in Canada
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • June 5 2018

In most jurisdictions, copyright owners often face numerous challenges when seeking to enforce their rights against media pirates. These challenges


Teva seeks leave in levofloxacin damages assessment
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • June 4 2018

The Federal Court of Appeal recently dismissed Teva's appeal regarding the quantification of damages for its infringement of Janssen's patent for


First CSPs issued and application fee increased
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • June 4 2018

Health Canada recently issued the first certificates of supplementary protection (CSPs) against three approvals. In addition, on April 1 2018 the CSP


Peering over the neighbours’ fence: key differences in trademark laws between Canada and the U.S.
  • Smart & Biggar/Fetherstonhaugh
  • USA, Canada
  • May 31 2018

As trade talks between Canada and the United States dominate the headlines, it is hard to ignore the strong economic ties between these neighbouring